Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomes.
Hesham ElsabahRola GhasoubDina S SolimanFeryal IbrahimMahmood B AldaptRuba Y TahaSafaa Al AzawiDeena MudawiAbbas MoustafaHalima ElomriHonar CherifPublished in: Cancer reports (Hoboken, N.J.) (2024)
Skull base plasmacytoma represents a rare manifestation of plasma cell neoplasms, underscoring the importance of considering it in the differential diagnosis of skull base lesions to ensure early intervention and avoid potential serious complications. Throughout our series, the cornerstone of therapy involved radiotherapy, systemic myeloma therapy, and ASCT, all of which elicited a favorable response in every case.
Keyphrases
- newly diagnosed
- end stage renal disease
- randomized controlled trial
- ejection fraction
- chronic kidney disease
- cell therapy
- early stage
- radiation therapy
- prognostic factors
- stem cells
- peritoneal dialysis
- middle aged
- locally advanced
- squamous cell carcinoma
- risk assessment
- mesenchymal stem cells
- radiation induced
- patient reported
- rectal cancer